Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
ID: 351450Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/351450

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-082.html
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Dec 12, 2023 12:00 AM
  4. 4
    Due Mar 13, 2024 12:00 AM
Description

The National Institutes of Health (NIH) is offering a grant opportunity titled "Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)". This grant aims to support the discovery of the genetic basis of childhood cancers and structural birth defects through the Gabriella Miller Kids First Pediatric Research Program. The program encourages the submission of samples from pediatric cohorts for whole genome sequencing at a Kids First Program-supported sequencing center. The goal is to elucidate the genetic contribution to childhood cancers, investigate the genetic etiology of structural birth defects, study the molecular basis of the associations between birth defects and increased cancer risk, and expand the range of pediatric disorders included within the Kids First Data Resource. The program accepts proposals for whole genome, exome, and transcriptome sequencing, as well as epigenomic assays of tumor or affected tissue. Applicants are encouraged to propose cohorts of underrepresented racial and ethnic groups or increase representation in existing Kids First Program projects. The data, along with associated clinical and phenotypic data, will be shared with the research community through the Kids First Data Resource Center. For more information and to apply, visit the NIH grants website at http://grants.nih.gov/grants/guide/pa-files/PAR-24-082.html.

Point(s) of Contact
grantsinfo@nih.gov
Files
Title
Posted
PAR-24-082-Full-Announcement.html
4/10/2024
Similar Opportunities
Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)". This grant aims to support innovative research that will enhance our understanding of the mechanisms underlying the formation of structural birth defects. The research will utilize animal models in conjunction with human translational/clinical approaches. The grant encourages the use of advancements in genetics, omics methods, synthetic biology, and other developmental biology research approaches to identify specific genetic, epigenetic, environmental, or gene/environment interactions associated with the formation, susceptibility, and variability of structural birth defects in human populations. The grant does not require cost sharing or matching requirements and is open to various eligible applicants. The closing date for applications is September 7, 2025. For more information and to apply, visit the following link: [Advancing Research to Understand Congenital Malformations Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-22-215.html).
Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed)". This grant falls under the category of Income Security and Social Services. The purpose of this initiative is to promote the screening, functional validation, and characterization of birth defects-associated genetic variants identified through public-facing databases and individual efforts. The grant aims to utilize in-silico tools, appropriate animal models, in vitro systems, or multi-pronged approaches to study these genetic variants. The funding instrument for this grant is a Grant, and there is no cost sharing or matching requirement. The eligible applicants for this grant include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The closing date for this grant opportunity is May 7, 2025. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-21-229.html](http://grants.nih.gov/grants/guide/pa-files/PAR-21-229.html).
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)". This grant aims to support research focused on the development of new screening approaches and therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening. The grant also targets "high priority" genetic conditions where screening may be possible in the near future. The grant encourages the development of accurate screening tests and the demonstration of the benefits of early intervention or treatment for these conditions. The maximum award ceiling for this grant is $275,000. Eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The deadline for applications is November 16, 2024. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-21-355.html](http://grants.nih.gov/grants/guide/pa-files/PAR-21-355.html). For any inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional)". This grant aims to support research related to the development of new screening approaches and therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening. It also focuses on "high priority" genetic conditions where screening may be possible in the near future. The grant seeks to identify accurate screening tests and demonstrate the benefits of early intervention or treatment for these conditions. The funding amount for this grant is up to $50,000. Eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The deadline for applications is November 16, 2024. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-21-354.html](http://grants.nih.gov/grants/guide/pa-files/PAR-21-354.html).
Omics Phenotypes Related to Down Syndrome for the INCLUDE Project (X01 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "Omics Phenotypes Related to Down Syndrome for the INCLUDE Project" in the category of Income Security and Social Services. This grant aims to generate a large volume of integrated genomic and multi-omics data to understand the molecular mechanisms of health conditions related to Down syndrome. The data, along with associated clinical and phenotypic data, will be shared with the research community through the INCLUDE Project data resource. The grant encourages applicants to propose omics essays of existing biospecimens collected from individuals with Down syndrome and controls. Whole genome sequencing, exome sequencing, epigenome sequencing, transcriptome sequencing, proteomic sequencing, metabolomic sequencing, and single-cell RNA sequencing are among the proposed techniques. The grant also encourages the inclusion of underrepresented racial and ethnic groups in the proposed cohorts. The omics data and related phenotypic data will be deposited in a public INCLUDE Project controlled-access database. The grant does not provide direct funding to applicants. For more information and to apply, visit the following link: [Additional Information](http://grants.nih.gov/grants/guide/pa-files/PAR-24-081.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.